Cutaneous Leishmaniasis Completed Phase 3 Trials for Imiquimod (DB00724)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00257530Imiquimod Plus Antimony Immunochemotherapy for Cutaneous LeishmaniasisTreatment